Patient, Physician, and Payment Predictors of Statin Adherence

被引:158
作者
Chan, David C. [2 ]
Shrank, William H. [1 ]
Cutler, David [3 ]
Jan, Saira [4 ]
Fischer, Michael A. [1 ]
Liu, Jun [1 ]
Avorn, Jerry [1 ]
Solomon, Daniel [1 ]
Brookhart, Alan [1 ]
Choudhry, Niteesh K. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Div Pharmacoepidemiol & Pharmacoecon,Brigham & Wo, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02115 USA
[3] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA
[4] Rutgers State Univ, Piscataway, NJ USA
关键词
adherence; relative importance; explanatory model; patient; physician; payment; CORONARY-HEART-DISEASE; MEDICATION ADHERENCE; PRESCRIPTION DRUGS; PHARMACY BENEFITS; THERAPY; PREVENTION; DISCONTINUATION; PRAVASTATIN; TRUST; RATES;
D O I
10.1097/MLR.0b013e3181c132ad
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited. Objectives: To measure the contributions of patient, physician, and payment predictors in explaining adherence to statins. Research Design: Retrospective cohort study using administrative data. Subjects: A total of 14,257 patients insured by Horizon Blue Cross Blue Shield of New Jersey who were newly prescribed a statin cholesterol-lowering medication. Measures: Adherence to statin medication was measured during the year after the initial prescription, based on proportion of days covered. The impact of patient, physician, and payment predictors of adherence were evaluated using multivariate logistic regression. The explanatory power of these models was evaluated with C statistics, a measure of the goodness of fit. Results: Overall, 36.4% of patients were fully adherent. Older patient age, male gender, lower neighborhood percent black composition, higher median income, and fewer number of emergency department visits were significant patient predictors of adherence. Having a statin prescribed by a cardiologist, a patient's primary care physician, or a US medical graduate were significant physician predictors of adherence. Lower copayments also predicted adherence. All of our models had low explanatory power. Multivariate models including patient covariates only had greater explanatory power (C = 0.613) than models with physician variables only (C = 0.566) or copayments only (C = 0.543). A fully specified model had only slightly more explanatory power (C = 0.633) than the model with patient characteristics alone. Conclusions: Despite relatively comprehensive claims data on patients, physicians, and out-of-pocket costs, our overall ability to explain adherence remains poor. Administrative data likely do not capture many complex mechanisms underlying adherence.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 36 条
[1]  
Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
[2]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[3]   DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS [J].
ANDRADE, SE ;
WALKER, AM ;
GOTTLIEB, LK ;
HOLLENBERG, NK ;
TESTA, MA ;
SAPERIA, GM ;
PLATT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1125-1131
[4]   Long-term persistence in use of statin therapy in elderly patients [J].
Benner, JS ;
Glynn, RJ ;
Mogun, H ;
Neumann, PJ ;
Weinstein, MC ;
Avorn, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04) :455-461
[5]   Physician follow-up and provider continuity are associated with long-term medication adherence - A study of the dynamics of statin use [J].
Brookhart, M. Alan ;
Patrick, Amanda R. ;
Schneeweiss, Sebastian ;
Avorn, Jerry ;
Dormuth, Colin ;
Shrank, William ;
van Wijk, Boris L. G. ;
Cadarette, Suzanne M. ;
Canning, Claire F. ;
Solomon, Daniel H. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (08) :847-852
[6]   Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies [J].
Choudhry, Niteesh K. ;
Brennan, Troyen ;
Toscano, Michele ;
Spettell, Claire ;
Glynn, Robert J. ;
Rubino, Mark ;
Schneeweiss, Sebastian ;
Brookhart, Alan M. ;
Fernandes, Joaquim ;
Mathew, Susan ;
Christiansen, Blake ;
Antman, Elliott M. ;
Avorn, Jerry ;
Shrank, William H. .
AMERICAN HEART JOURNAL, 2008, 156 (01) :31-36
[7]   Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients [J].
Choudhry, Niteesh K. ;
Setoguchi, Soko ;
Levin, Raisa ;
Winkelmayer, Wolfgang C. ;
Shrank, William H. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (12) :1189-1196
[8]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[9]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[10]  
Eriksson M, 1998, J INTERN MED, V243, P373